News

Search EMA's news announcements

Резултати (3799)

Regulatory update - EMA encourages companies to submit type I variations for 2022 by end of November

3 November 2022

NewsCorporateMedicines

EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders

3 November 2022

NewsHumanReferrals

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022

28 October 2022

NewsHumanPharmacovigilanceReferrals

EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines

28 October 2022

NewsHumanMedicinesReferrals

EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November

28 October 2022

NewsCorporateCOVID-19

EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age

19 October 2022

NewsHumanCOVID-19Vaccines

EMA recommends approval of second adapted Spikevax vaccine

19 October 2022

NewsHumanCOVID-19Vaccines

New vaccine to protect people in the EU and worldwide against dengue

14 October 2022

NewsHumanMedicinesMedicines for use outside the EU

First therapy to treat transplant patients with post-transplant lymphoproliferative disease

14 October 2022

NewsHumanMedicines

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022

14 October 2022

NewsHumanCOVID-19MedicinesMedicines for use outside the EU